Park Ha Biological Technology Co., Ltd. Ordinary Shares
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Xiaoqiu Zhang
- Full Time Employees
- 41
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- Building C Wuxi JS People's Republic of China 214100
- IPO Date
- Dec 27, 2024
- CIK
- 0001986247
- Website
- parkha.cn
- Similar Companies
- Business
- Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH) develops and sells private-label skincare products under its proprietary Park Ha brand in China; operates in the Product Sales and Franchise Service segments; and provides complementary after-sales beauty services including light beauty experiences in directly operated and franchise stores. The company offers nearly 128 skincare products across 14 series covering basic skin physical protection, exfoliation, sebum film repair, surface microecological balance, and anti-aging categories; star products include the Little Blue Injection Serum, featuring multiple peptide active substances for hydration, moisturizing, brightening, and firming, as well as freeze-dried powders with fibronectin and cherry blossom extract for firmer, tender skin; additional offerings comprise Park Ha Amino Acid Cleansing Foam and other formulations developed through in-house research at its Jiangsu Park Ha Biological Technology Co., Ltd. subsidiary in collaboration with institutions like Jiangnan University, with production outsourced to licensed third-party manufacturers under strict ingredient and quality controls. Founded in 2016 and headquartered at 901 & 901-2, Building C, Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, People's Republic of China, the company conducts operations through Chinese subsidiaries Jiangsu Park Ha Biological Technology (R&D and direct stores), Shanghai Park Ha Industrial Development (franchisee training), and Wuxi Xinzhan Enterprise Management Consulting (marketing and franchising); as of April 30, 2024, it maintains two directly operated stores and 43 franchisees, with 41 under the Park Ha name and two under Geni. In December 2024, Park Ha completed a $4.8 million initial public offering on Nasdaq Capital Market by selling 1,200,000 ordinary shares at $4.00 each, granting underwriters a 45-day option for 180,000 additional shares, with net proceeds allocated to expanding directly owned stores in China, acquiring product patents for proprietary development, and purchasing ingredient suppliers to lower long-term production costs; the company operates as a subsidiary of Xiaoqiu Holding Ltd.
Company News
BYAH Investor Alert: Park Ha Biological Technology Co., Ltd. Securities Class Action Notice - Contact SueWallSt
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
BYAH Stock Drop: Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Park Ha Biological Technology Co, Ltd
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
BYAH Deadline Alert: Levi & Korsinsky Reminds Park Ha Biological Technology Co. (BYAH) Investors of Securities Class Action Deadline on September 28, 2026
ROSEN, A NATIONAL AND LEADING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines – BYAH
BYAH UPCOMING DEADLINE: SueWallSt Alerts Park Ha Biological Technology Co., Ltd. Stockholders of Securities Class Action - Contact the Firm
ROSEN, A TOP-RANKED LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
BYAH Shareholder Alert: Park Ha Biological Technology Co., Ltd. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH
ROSEN, TOP-RANKED INVESTOR RIGHTS COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
BYAH DEADLINE: SueWallSt Reminds Park Ha Biological Technology Co., Ltd. Investors of Upcoming Securities Class Action Deadline
PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit
Robbins LLP Urges Investors of Park Ha Biological Technology Co, Ltd. to Contact the Firm for Information About the BYAH Securities Class Action Lawsuit
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm